West Ujimqin Banner, Xilingol League, Inner Mongolia, China sales9@alchemist-chem.com 1531585804@qq.com
Follow us:



Eicosapentaenoic Acid Ethyl Ester (EPA-EE): Past Lessons and Future Pathways

Historical Development

Interest in omega-3 fatty acids got going in the late 1970s with studies of Greenland Eskimo diets. People saw indigenous diets heavy in fish didn’t come with the same rate of heart attacks seen in communities eating more saturated fat. Eicosapentaenoic acid, or EPA, appeared on researchers’ radars. Demand for chemical purity nudged companies to refine extraction and synthesis. By the 1990s, methods for turning fish oil into concentrated ethyl esters started to dominate. The reason for this approach comes down to efficiency: by converting EPA into its ethyl ester form, supplement makers can reach higher purity and guarantee standard dosages. Drug developers jumped on this, too, since the process allowed precise control over dose for use in clinical studies and as prescription products for lowering high triglycerides.

Product Overview

EPA-EE stands as a pharmaceutical-grade omega-3 fatty acid derivative. Turning EPA into its ethyl ester form means separating it from other fatty acids and binding it to ethanol. The result is a much more stable compound compared to native triglyceride forms. EPA-EE appears in translucent, pale yellow, oily liquid form and smells faintly fishy, which comes as no surprise for anyone who’s spent time near the source. Suppliers now offer purity levels above 95%, with careful attention to pesticide residues, heavy metals, and other contaminants. No longer just a generic fish oil, EPA-EE has become the mainstay for prescription products treating hypertriglyceridemia, thanks to clear clinical data showing it can help lower blood lipid levels and reduce cardiovascular risk.

Physical & Chemical Properties

EPA-EE boils at around 210°C under reduced pressure, which helps with industrial distillation. With a molecular formula of C22H34O2, its ethyl ester version increases lipophilicity over the free fatty acid, helping improve its shelf life and resistance to oxidation. That means less rancidity, which matters for consumer quality. Even though it’s not especially water soluble, it blends well with edible oils or encapsulates cleanly in softgels. The characteristic double bonds in the omega-3 chain keep EPA-EE fluid at room temperature, preventing crystallization under normal conditions. Recognizing these features helps manufacturers design better storage and handling protocols, since even trace contamination or improper storage accelerates degradation.

Technical Specifications & Labeling

Most high-purity EPA-EE now comes with specifications for content (usually >90%), acid value, peroxide value, and heavy metal thresholds, especially mercury, lead, arsenic, and cadmium. Detailed labeling rules demand listing active EPA content, capsule excipients, country of origin, and batch numbers. For pharmaceutical grades, regulatory guidance from agencies like the FDA and EMA requires Good Manufacturing Practice certification, validated cleaning protocols, and robust analytical testing, including gas chromatography for purity and isomer ratios. Nutrition supplements must cite their daily value statement, storage conditions—preferably below 25°C, out of direct sunlight—and an expiration date based on accelerated shelf life testing. Many labels also now highlight allergen concerns, such as possible fish or shellfish traces, making consumer protection a front-and-center promise rather than a buried footnote.

Preparation Method

Production of EPA-EE usually starts by extracting natural fish oil, then separating out unwanted fats through winterization and molecular distillation. Saponification splits the oil into glycerol and free fatty acids. These fatty acids are then reacted with ethanol in the presence of an acid or base catalyst, creating ethyl esters. Precision filtration and further molecular distillation remove residual ethanol, catalyst, and impurities, concentrating the EPA. High-performance liquid chromatography checks for unwanted isomers. Manufacturers who invest in continuous-flow or supercritical fluid extraction see higher yields and fewer contaminants. Traceability at every step remains non-negotiable since unchecked supply chains risk adulteration and introduce harmful environmental residues from overharvested fisheries.

Chemical Reactions & Modifications

EPA-EE itself resists many reactions that spoil native triglyceride forms. Still, it undergoes transesterification for further purification or for creating tailor-made blends with other omega-3s. Chemical researchers leverage the double bonds for selective hydrogenation (to create derivatives with altered properties) or for crosslinking in polymer development. One growing area uses mild enzymatic reactions to improve the bioavailability of EPA-EE or to attach it to other carrier molecules, possibly improving absorption in the gut. As consumer awareness about oxidation continues to rise, antioxidants such as tocopherols or rosemary extract often join the formulation to protect EPA from oxidation, which would otherwise reduce potency and create unpleasant odors.

Synonyms & Product Names

EPA-EE appears in the literature and on product labels under several names, including Icosapent Ethyl, Eicosapentaenoic Acid Ethyl Ester, and 5,8,11,14,17-Eicosapentaenoic acid, ethyl ester. Widely marketed prescription brands—most notably Vascepa—show just how far this refined omega-3 has come from its origins in fish oil capsules. Even in the dietary supplement world, “pharmaceutical-grade EPA” or “ultra-pure EPA ethyl ester” hint at the same chemical, with varying regulatory oversight determined by intended use. Still, many products ride on the reputation of clinical pharmaceuticals, even though their EPA-EE content often falls short of that level of precision or refinement.

Safety & Operational Standards

Handling EPA-EE in a manufacturing environment takes more than gloves and goggles. Production plants build in fail-safes against cross-contamination and use controlled, low-temperature environments to minimize risk of oxidation and fire. With flash points above 190°C, EPA-EE doesn’t present the same explosion risk as volatile solvents, but oxidation can still generate flammable peroxides if left unmanaged. Regulatory guidelines insist on regular equipment cleaning, solvent management, and strict adherence to purity testing. Operator training remains essential since trace chemical residues or careless storage can destroy the batch and introduce health hazards if oxidized components make their way to consumers. Most large producers use closed-system transfer lines and nitrogen blanketing to suppress airflow and protect EPA-EE from light and heat during storage.

Application Area

The most prominent application for EPA-EE sits in cardiometabolic health, with regulatory approval for lowering triglycerides and, in some cases, reducing cardiovascular event risk. Medical journals regularly report secondary benefits in inflammation control for rheumatoid arthritis, though strong clinical consensus stops short of full endorsement for these uses. Smaller-scale trials explore EPA-EE’s role in neurology, with some evidence linking EPA to cognitive support and mood stabilization. Sports nutrition brands bundle EPA-EE into recovery and muscle soreness blends. Skincare researchers look at anti-inflammatory effects and possible improvements in skin barrier integrity. Animal nutrition and aquaculture businesses also pick up EPA-EE for specialized feed to boost omega-3 profiles in farmed fish or high-performance pets, though the focus there stays on cost-control rather than pharmaceutical standards.

Research & Development

A wave of clinical and preclinical research continues to chase after new uses for EPA-EE. The REDUCE-IT trial grabbed headlines showing high-purity EPA ethyl ester lowers the risk of major cardiovascular events in certain populations, something not achieved by mixed omega-3 supplements. Researchers now probe whether EPA-EE can slow the progress of nonalcoholic fatty liver disease, boost recovery after stroke, or support mental health in major depressive disorder. On the manufacturing side, R&D teams experiment with microencapsulation, water-dispersible forms, and co-formulation with antioxidants—all in service of better absorption and stability. Sustainability also turns up, with scientists investigating fermentation-based EPA production using algae or synthetic biology, a shift away from ocean-sourced fish oil. As global demand grows, these alternative supply chains could become decisive.

Toxicity Research

EPA-EE generally earns high marks for safety in recommended doses. Large clinical trials reveal low rates of serious adverse effects, principally mild gastrointestinal upset or fishy burps. On the toxicological front, chronic exposure studies in rats and other mammals show little evidence of long-term harm, even at doses much higher than those prescribed to humans. Concerns sometimes focus on possible effects on blood clotting, especially for those already taking anticoagulants. As a result, careful monitoring in these groups remains prudent. Quality control stands crucial since poorly refined products carry risks from environmental contaminants—namely dioxins, PCBs, and heavy metals. Ongoing toxicity profiling has also broadened to include oxidation metabolites, which could exert pro-inflammatory or cytotoxic effects if left unchecked during storage or processing.

Future Prospects

The landscape for EPA-EE broadens as new scientific questions open doors. Demand for cleaner, plant-based, or fermentation-derived sources keeps rising with concern over declining fish stocks and growing vegan populations. Pharma companies want purer, custom-tailored forms for specialty diseases, deepening reliance on synthetic biology and green chemistry processes. Smart packaging, analytical sensors, and QR-code traceability promise to boost transparency. Politics and global trade stay in play, since many fisheries straddle international waters and supply chains crisscross the globe. Education for doctors and consumers helps cut through marketing claims and push for clear benefits—such as the evidence-backed reduction in major cardiovascular events—over general supplement promises. The next decade very likely writes a story not just of improved production but also of real measurable effect in specific populations, faster product customization, and true stewardship across the omega-3 ecosystem.




What is Eicosapentaenoic Acid Ethyl Ester (EPA-EE) used for?

The Heart of the Matter

Ask a cardiologist about fish oil and the term EPA-EE usually comes up pretty quickly. This ingredient is a refined form of the omega-3 fatty acid found in certain fish oils. Doctors and researchers have studied it for years, focusing on how it supports heart health—especially for people with high triglycerides. EPA-EE lowers these blood fats, which is important because high triglycerides increase the risk of cardiovascular problems. Growing up in a family where heart disease felt like a regular topic at the dinner table, it hits home for me. Many people wrestle with cholesterol, but triglycerides can be just as sneaky and dangerous.

Beyond the Basics: Clinical Use

EPA-EE isn’t just a supplement people pick up on a whim at the local pharmacy. In prescription form, doctors use it to treat specific health problems. One of the best-known products containing EPA-EE is Vascepa. The FDA approved it to help lower triglyceride levels in adults with severe hypertriglyceridemia. The numbers on this get my attention—some clinical trials, like REDUCE-IT, reported nearly a 25% reduction in major cardiovascular events among high-risk patients taking EPA-EE. That means fewer heart attacks, strokes, and hospital visits for a lot of people.

Why Quality Matters

Not all omega-3 sources deliver the same result. Over-the-counter fish oil often mixes EPA with its cousin, docosahexaenoic acid (DHA), and the actual concentration can swing wildly from bottle to bottle. With pure EPA-EE, quality standards and dosing stay controlled. People with cardiovascular risk can work with their doctor to find the right plan, instead of rolling the dice with supplements that barely move the needle. As someone who used to scan health aisles, comparing supplement labels, this clarity feels like a relief.

The Science Backs It Up

EPA-EE works by reducing the liver’s ability to synthesize triglycerides. This lowers blood fat levels, protecting arteries and supporting better blood flow. Studies show additional benefits for blood pressure, inflammation, and potentially even mental health. Large analyses in leading journals like New England Journal of Medicine highlight how EPA lowers cardiovascular risk, especially in people already battling chronic issues like diabetes or metabolic syndrome.

Potential Solutions and Next Steps

A practical move is getting regular blood work and talking honestly with a healthcare provider about cardiovascular risk. For people with stubbornly high triglycerides, prescription EPA-EE gives a science-backed option. Insurance and access remain real hurdles; advocacy from patients and providers keeps these advanced treatments on the table for more people. Diet and lifestyle changes matter, but medication like EPA-EE can plug the gaps that leafy greens and jogs around the block just don’t fill for some folks.

Looking Ahead

Ongoing research looks at whether EPA-EE might help with other inflammatory conditions or specific mental health concerns. For now, the strongest evidence sits with heart health and triglyceride reduction. As more doctors and patients learn about its benefits, EPA-EE takes on a larger role in fighting the widespread impact of cardiovascular disease.

Are there any side effects associated with EPA-EE?

Understanding EPA-EE

EPA-EE stands for eicosapentaenoic acid ethyl ester. Most people know it as one of the main components of prescription fish oil. Doctors sometimes recommend EPA-EE for people trying to manage high triglyceride levels. You’ll find it in products like Vascepa. There’s a ton of research looking at the benefits of omega-3s—lowering the risk of heart attacks, strokes, and more. EPA-EE usually gets singled out because it’s just the EPA component without DHA, another omega-3, which helps avoid certain unwanted effects on cholesterol.

So, Are There Side Effects?

No pill or supplement comes without risks. EPA-EE can trigger some unwanted reactions, and transparency around this matters. Some folks report mild stomach upset—think nausea, diarrhea, or burping. Most of these stick to the digestive tract. Anyone who has tried prescription-level fish oil has probably had a fishy aftertaste and stomach gurgling. Those symptoms rarely last if you take the med with food.

A less-discussed point is the potential for slight increases in bleeding risk. EPA-EE can affect how platelets clump together, especially at high doses. It doesn’t thin blood like a strong anticoagulant, but in people who already take blood thinners—like warfarin or certain newer drugs—there’s a higher risk of bruises or a nosebleed that lasts too long. The big clinical studies (like REDUCE-IT) tracked side effects and didn’t turn up a high number of major bleeding events, but people still need to use common sense and talk to their healthcare provider if they’re already taking other blood-thinning meds.

Some people taking EPA-EE feel joint or muscle pain. This is tricky to pin directly on the drug, since joint problems are common in the same population—older adults with heart disease or high cholesterol. Still, it gets mentioned enough that doctors ask about it at follow-ups.

Liver function comes up every time a new prescription hits the market. With EPA-EE, significant liver issues haven’t really popped up. Occasionally, blood tests might show a slight bump in liver enzymes, but that tends to return to normal over time. Still, folks with past liver troubles shouldn't ignore new prescriptions without asking questions.

Allergies remain rare. The vast majority of EPA-EE products are highly purified and free of proteins that trigger fish allergies. If you know you’re highly allergic to fish, it’s smart to bring that up with your doctor before starting any omega-3 prescription.

Minding the Details and Thinking Ahead

People need honest communication about both benefits and risks. Large, careful studies show EPA-EE helps heart health for some people, but that’s not a guarantee for everyone. The biggest side effects—mild stomach symptoms or maybe higher bleeding risk—shouldn’t scare folks off from asking questions, but shouldn’t be brushed aside either. Anyone on blood thinners, or with a history of easy bruising, should dig deeper and read up. Regular blood checks can pick up any liver or clotting changes early. Whenever side effects crop up, reporting them makes a difference—nobody benefits when problems stay hidden.

Good medical care should feel like a partnership. Shared decision-making gives patients a safe place to speak up about side effects instead of suffering in silence. For EPA-EE, a healthy skepticism paired with open-minded discussion paves the way to better outcomes. If people know what to watch for, they can make choices rooted in facts—not hype or fear.

How should EPA-EE be taken or dosed?

Fish Oil’s Modern Cousin

Plenty of health headlines throw around words like “omega-3s” and “EPA,” but things get technical fast. Among the sea of supplements, EPA-EE, or eicosapentaenoic acid ethyl ester, does its job by delivering a bioavailable form of omega-3. In my own experience working at a health food store, I got countless questions about whether to buy plain fish oil or some “fancier” EPA pill on the shelf. Things didn’t always add up for customers keen to support their heart, joints, or brain but lost when it came to the nitty gritty of dosing.

Popping Pills Doesn’t Guarantee Results

EPA-EE isn’t your average softgel. Unlike the naturally occurring triglyceride form, this version shows up in an ethyl ester shell—a tweak that makes a surprising difference in absorption. The body isn’t a simple pipeline; it treats EPA-EE differently than fish oil, working to snip off that extra ethyl piece before absorbing the actual EPA. That step relies on pancreatic enzymes. In some people—especially anyone with less-than-perfect digestion—this detail shapes how much EPA reaches circulation, which can sway the benefits.

One thing I found over years of talking to supplement users: many are confident a high milligram label means more health insurance. Science paints a muddier picture. Studies show natural fish oil forms can absorb up to three times more efficiently than EPA-EE unless EPA-EE gets taken with a fatty meal. Skipping breakfast to wash down a capsule with coffee cuts what actually gets used. People hoping for clinical trial effects but downing these on an empty stomach burn through money—and don’t get the boost they expected.

What Dosing Really Means

Recommended doses for heart health or high triglycerides usually fall in the range of 1 to 4 grams of EPA (plus DHA) per day, but for EPA-EE, the number on the bottle only tells half the story. Doctors prescribing “prescription-strength” omega-3s often check blood levels down the road to fine-tune dosing, because it isn’t just about swallowing more capsules. High doses raise the risk of nosebleeds and affect how well blood clots. Folks taking blood thinners, or anyone with bleeding disorders, need a careful game plan.

The FDA approved high-dose EPA-EE for certain heart conditions, but nobody wins by guessing. Checking with a clinician before ramping up—especially above 1 gram daily—keeps the math honest. Even over-the-counter labels can understate or overstate what’s inside, based on findings from independent testing labs. One supplement brand I remember, known in our area for flashy ads, barely delivered half the promised content.

Where Diet Steps In

Supplements fill a gap, but they don’t fix a plate heavy on fried food and light on greens. I’ve met plenty of people at the checkout counter with bags of fish oil in one hand and instant noodles in the other. EPA-EE works best as part of a bigger plan: better food choices, realistic movement, and honest check-ins with your healthcare team. Not everyone’s needs run the same, and cutting corners with “more is better” doesn’t always turn out how you’d hope.

Taking EPA-EE calls for a glance at the big picture—meals, meds, lab results, and the goals that matter for you. Respect the label, but let your health professional help you steer the course. Real health usually means slow steps and real food, not magic in a capsule.

Is EPA-EE safe for long-term use?

What is EPA-EE?

EPA-EE stands for eicosapentaenoic acid ethyl ester, a purified form of omega-3 fatty acid often found in prescription fish oil products. Used to manage high triglycerides, it has become a staple for doctors treating heart patients—especially folks at risk for cardiovascular events.

Trust in the Science

Having spent years researching health topics and talking to physicians, I see caution and curiosity every time a new supplement or pharmaceutical gathers buzz. EPA-EE isn’t new, but the long-term question keeps popping up in online patient forums and in doctor’s offices. Are people safe to take it year after year, even decade after decade?

Clinical trials help light the way. The REDUCE-IT trial tracked over 8,000 adults at high cardiovascular risk. Patients took 4 grams of EPA-EE daily for a median of five years. Researchers saw a significant drop in heart attacks and strokes compared to a placebo group. Adverse events did surface—patients on EPA-EE more often showed bleeding and irregular heart rhythms like atrial fibrillation than people taking a sugar pill. These numbers didn't skyrocket out of control, according to published results, but the rise in bleeding and arrhythmia risk remains worth discussing openly with a doctor, particularly for anyone already dealing with clotting or heart rhythm issues.

The FDA approval process isn’t soft. Prescription EPA-EE products go through testing, scrutiny, and constant review. That said, science keeps moving. The experience of treating thousands of people offers far more insight than a carefully controlled trial alone. Real-world use sometimes exposes problems that trials miss. The supplement version, sold over the counter, doesn’t get the same review—so there’s more uncertainty there, especially about quality and purity.

Experience on the Ground

Talk to anyone taking prescription omega-3s for years, and patterns start to emerge. Many patients say the medicine helps control their numbers and doesn’t bother them much day to day. Still, a few talk about digestive side effects—burping, taste changes, and mild stomach upset. Some get their blood checked regularly and manage bleeding risks by staying extra aware if they also use aspirin, warfarin, or other blood thinners.

Doctors I’ve interviewed say the key lies in regular follow-ups and honest questions. People can’t expect a pill—even one with years of study—to answer every concern. Monitoring matters; it helps spot liver issues, cholesterol changes, new bleeding, or heart rhythm problems before they escalate.

Charting a Safer Path Forward

Long-term safety rests on a few legs: transparency, regular care, and high-quality evidence. Anyone considering EPA-EE should talk to their cardiologist, share a full medication list, and come prepared with questions. Don't forget lifestyle: diet, exercise, and smoking status carry weight too. Research continues to update the story, so what holds true today may look different after another decade of careful study. Everyone—doctors, patients, families—benefits from real experiences and open discussions, not just the smallest print in a clinical report.

Can EPA-EE interact with other medications or supplements?

Understanding EPA-EE and Its Potential for Drug Interactions

EPA-EE, a form of eicosapentaenoic acid made as an ethyl ester, shows up often in omega-3 supplements. The scientific interest in omega-3s goes back decades thanks to their role in supporting heart, brain, and joint health. As someone with a background in pharmacy practice, I've seen people grab these supplements thinking “it’s just fish oil—no harm done.” That’s always where the story gets complicated, because any supplement strong enough to help can also raise real concerns about mixing with other medicines.

Blood Thinning and Safety Signals

The biggest issue people need to know about is how EPA-EE can potentially thin the blood. Doctors often suggest omega-3s for those aiming to keep triglycerides down or reduce cardiovascular risk. But if you’re already taking anticoagulants—warfarin, clopidogrel, or even daily aspirin—it starts to matter. These medicines slow blood clotting by different pathways, and adding EPA-EE may ramp up your risk of bruising or more serious bleeding. Reports of nosebleeds, gum bleeding, or long-lasting bruises sometimes show up in the medical literature for those on this mix. A review in the Journal of the American Heart Association pinpoints this as a genuine concern, especially for people already prone to bleeding complications.

Interactions and Absorption: Not Just “Natural”

Some people believe natural means risk-free, but liver enzymes don’t make that distinction. EPA-EE gets processed by the liver enzyme CYP450. Many drugs—statins, blood pressure meds, even herbal products like St. John’s Wort—rely on the same metabolic pathways. Combining more than one thing that’s broken down by the liver can cause them to build up in the body. That can tip a standard dose into the danger zone, or reduce how well something works. It isn’t a theoretical worry—cases pop up in databases and in clinics, especially when people don’t share supplement habits with healthcare professionals.

The Supplement Stack Problem

It’s common to take more than one supplement without thinking twice. A bottle of EPA-EE, a capsule of vitamin E, and maybe some ginkgo biloba for good measure. The trouble? All three are linked to blood-thinning effects. Add that to regular prescription drugs and the safety margin gets thin. Older adults tend to collect new pills and develop new conditions, which magnifies the risk of unwanted cross-talk between the various substances in their system. Pharmacists and dietitians see the fallout—the sudden uptick in nosebleeds or unexpected changes in how prescriptions work.

Safe Use and Concrete Steps

People who want the benefits of EPA-EE should begin with a simple step: keep a list of every supplement and prescription. Take that list to every appointment and ask about risks. Product labels don’t always warn about these problems, so don’t expect a quick note on the bottle. Researchers haven’t tested every possible combination of supplements and medicines, so caution and honest conversation with a healthcare provider becomes more valuable than fancy packaging. If costs allow, talking with a pharmacist who understands drug interactions can head off weeks of trouble down the line. For anyone plugged into regular bloodwork or prescription renewals, a few extra questions today can dodge problems in the future—because the way our bodies handle drugs and supplements matters as much as the health claims on the label.

Eicosapentaenoic Acid Ethyl Ester EPA-EE
Names
Preferred IUPAC name Ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
Other names Ethyl eicosapentaenoate
EPA ethyl ester
Icosapent ethyl
Omacor
Vascepa
Epadel
Lotriga
Omega-3-acid ethyl esters (EPA component)
Pronunciation /ˌaɪˌkoʊsəˌpɛntəˌiːəˈnɒɪɪk ˈæsɪd ˈɛθɪl ˈɛstər ˌiːpiːˈeɪˌiːˈiː/
Preferred IUPAC name Ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
Other names Eicosapentaenoic acid ethyl ester
Ethyl eicosapentaenoate
EPA ethyl ester
Ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
Omacor
Vascepa (in combination with DHA ethyl ester in some markets)
Pronunciation /ˌaɪ.kə.səˌpɛn.təˌiː.nə.ɪk ˈæs.ɪd ˈiː.θɪl ˈɛs.tər ˌiːˌpiːˈeɪ ˈiːˈiː/
Identifiers
CAS Number 33449-47-9
Beilstein Reference 1722112
ChEBI CHEBI:83766
ChEMBL CHEMBL1237062
ChemSpider 54639551
DrugBank DB04573
ECHA InfoCard 100.220.611
EC Number 5.3.3.13
Gmelin Reference 805332
KEGG C08362
MeSH D000923
PubChem CID 9884620
RTECS number QT3905700
UNII DLK5OST8ZQ
UN number UN3272
CompTox Dashboard (EPA) DTXSID5064616
CAS Number Please see below: "86227-47-6
Beilstein Reference 1710808
ChEBI CHEBI:83524
ChEMBL CHEMBL1201591
ChemSpider 20547003
DrugBank DB03247
ECHA InfoCard 100.247.937
EC Number 94733-40-7
Gmelin Reference 522714
KEGG C06429
MeSH Eicosapentaenoic Acid Ethyl Ester
PubChem CID 644086
RTECS number RT0489600
UNII 0Z2FF83H5A
UN number UN3272
CompTox Dashboard (EPA) DTXSID4046047
Properties
Chemical formula C22H34O2
Molar mass 330.51 g/mol
Appearance Colorless to pale yellow oily liquid
Odor Odorless
Density 0.899 g/cm³
Solubility in water Insoluble in water
log P 4.27
Vapor pressure 1.16E-7 mmHg at 25°C
Acidity (pKa) 4.75
Basicity (pKb) 13.39
Magnetic susceptibility (χ) -87.6×10⁻⁶ cm³/mol
Refractive index (nD) “1.4660”
Viscosity Viscous liquid
Dipole moment 4.07 D
Chemical formula C22H34O2
Molar mass 330.51 g/mol
Appearance Colorless to pale yellow oily liquid
Odor Odorless
Density 0.9 g/cm³
Solubility in water Insoluble in water
log P 3.8
Vapor pressure < 1 mm Hg (20 °C)
Magnetic susceptibility (χ) -6.3 × 10⁻⁶ cm³/mol
Refractive index (nD) 1.463
Viscosity Oil type: 32.8 cP (20°C)
Dipole moment 4.07 D
Thermochemistry
Std molar entropy (S⦵298) 654.6 J·mol⁻¹·K⁻¹
Std enthalpy of formation (ΔfH⦵298) –757.1 kJ/mol
Std enthalpy of combustion (ΔcH⦵298) -12770 kJ/mol
Std molar entropy (S⦵298) 671.3 J·mol⁻¹·K⁻¹
Std enthalpy of formation (ΔfH⦵298) Std enthalpy of formation (ΔfH⦵298) of Eicosapentaenoic Acid Ethyl Ester EPA-EE: -1677.2 kJ/mol
Std enthalpy of combustion (ΔcH⦵298) -12920 kJ/mol
Pharmacology
ATC code C10AX06
ATC code C10AX06
Hazards
GHS labelling GHS02, GHS07
Pictograms GHS07,GHS08
Signal word Warning
Hazard statements H315, H319, H335
Precautionary statements Precautionary statements: P210, P233, P240, P241, P242, P243, P260, P264, P270, P273, P301+P310, P303+P361+P353, P304+P340, P305+P351+P338, P312, P321, P330, P370+P378, P403+P235, P405, P501
NFPA 704 (fire diamond) NFPA 704: 1-1-0
Flash point > 113.2 °C
Autoignition temperature 425 °C
Lethal dose or concentration LD₅₀ (Mouse, oral): >5000 mg/kg
LD50 (median dose) LD50 (median dose): >5000 mg/kg (rat, oral)
NIOSH Not Listed
PEL (Permissible) PEL (Permissible Exposure Limit) for Eicosapentaenoic Acid Ethyl Ester EPA-EE: Not established
REL (Recommended) 2 g/day
IDLH (Immediate danger) Not Listed
Main hazards May cause eye, skin, and respiratory irritation.
GHS labelling GHS02, GHS07
Pictograms GHS07, GHS08
Signal word Warning
Hazard statements H410: Very toxic to aquatic life with long lasting effects.
Precautionary statements P261, P273, P301+P312, P305+P351+P338, P501
NFPA 704 (fire diamond) NFPA 704: 1-1-0
Flash point > 113°C
Lethal dose or concentration LD₅₀ (rat, oral): >5000 mg/kg
LD50 (median dose) LD50 (median dose): Oral, Rat: > 5,000 mg/kg
NIOSH Not Listed
PEL (Permissible) Not established
REL (Recommended) 2 g daily
Related compounds
Related compounds Icosapent ethyl
Docosahexaenoic acid (DHA)
Omega-3-acid ethyl esters
Alpha-linolenic acid
Fish oil
Linoleic acid
Related compounds Icosapent ethyl
Docosahexaenoic acid ethyl ester (DHA-EE)
Fish oil
Omega-3 fatty acids
Eicosapentaenoic acid (EPA)